Essential list of medicinal products for rare diseases: recommendations from the IRDiRC Rare Disease Treatment Access Working Group

Overview of attention for article published in Orphanet Journal of Rare Diseases, July 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

policy: 1 policy source

twitter: 15 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 42 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Uptake of orphan drugs in the WHO essential medicines lists

Cited by World Health Organization on 07 Jan 2024

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

The social contract and human rights bases for promoting access to effective, novel, high-priced medicines

Cited by World Health Organization on 31 Aug 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.